Second, in a rat kindling model of temporal lobe epilepsy, 2-DG reduced seizure progression by reducing the expression of brain-derived neurotrophic factor (BDNF) and its receptor, TrkB; this reduced expression is mediated by the decreasing of transcription factor NRSF caused by 2-DG administration (11). Here, BDNF is linked to temporal lobe epilepsy.